A racemic methamphetamine dose contains equal amounts of its two enantiomers. That does not mean urine will contain equal amounts of their corresponding metabolites. Li and colleagues’ 2010 controlled experiment showed substantial stereoselectivity, particularly in the urinary recovery of amphetamine formed after methamphetamine administration.
What was the experimental design?
Twelve healthy male intravenous methamphetamine users participated in a six-session, double-blind, placebo-controlled crossover study. They were not methamphetamine-dependent under the study criteria. Each person received S-(+)-methamphetamine at 0.25 and 0.5 mg/kg, R-(−)-methamphetamine at those doses, racemic methamphetamine at 0.5 mg/kg total, and placebo on separate occasions.
The racemic condition supplied 0.25 mg/kg of each enantiomer, rather than 0.5 mg/kg of each. Infusions were intravenous over one minute, with sessions approximately one week apart. These conditions must remain attached to the findings; they are not oral-dose or inhaler experiments.
Which specimens and quantities were analyzed?
The study collected urine over intervals ending at 4, 8, 12, 24 and 48 hours, recording each interval’s volume. Chiral gas chromatography–mass spectrometry separated and measured the enantiomers and metabolites. Serial blood sampling supported the related plasma pharmacokinetic analyses.
Urinary recovery expresses the amount measured over collection intervals relative to the administered dose. It is not the same quantity as the concentration in a single spot urine, which also depends on urine volume. Nor is recovered metabolite necessarily the entire amount formed throughout the body.
What showed the strongest stereoselectivity?
Approximately 6–7% of the S-(+)-methamphetamine dose was recovered as corresponding amphetamine, compared with approximately 2% of the R-(−) dose. The difference was significant (p<0.001). Hydroxylated methamphetamine showed a smaller enantiomer difference.
More unchanged R-(−)-methamphetamine than S-(+)-methamphetamine was recovered in urine. Thus, the parent drug and different metabolites did not all share one common enantiomer pattern. A generic “amphetamine-type stimulant ratio” would obscure what was actually measured.
Did the proportions stay constant over time?
After the racemic dose, the average S/R ratio of cumulative amphetamine recovery was approximately 6:1 at four hours and approximately 3:1 at forty-eight hours. The corresponding parent-methamphetamine ratio changed from approximately 1:1 to 0.7:1.
These were ratios of cumulative recovered amounts in a controlled protocol. They should not be silently substituted for ratios from one forensic spot sample. The differing patterns show why metabolite stereochemistry cannot simply be copied back onto the original consumed material.
What uncertainty limits individual interpretation?
The study found substantial between-person variation, including one participant with unusually low metabolite formation. The authors considered a possible CYP2D6 explanation, but did not genotype participants. An interesting outlier therefore did not establish that individual’s genotype.
Urine pH was not measured, despite its known relevance to urinary elimination discussed by the authors. The sample contained only twelve men and tested specific single intravenous regimens. Repeated use, other substances and different exposure routes require additional evidence.
This experiment supports stereoselective metabolism and recovery under its tested conditions. It does not validate an exact last-use clock, a universal source-composition correction or an impairment estimate. The practical question for a disputed ratio is which analyte, specimen, collection interval and calculation produced it—not merely whether the original drug was racemic.
Source
Li L, Everhart T, Jacob P III, Jones R, Mendelson J. Stereoselectivity in the human metabolism of methamphetamine. British Journal of Clinical Pharmacology. 2010;69(2):187–192. doi:10.1111/j.1365-2125.2009.03576.x.
Leave a Reply